FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Acambis | Vaccine | contract

SPOTLIGHT: Acambis contract offers long-term funding

Tools


The announcement that Acambis has won a $425 million, 10-year contract to supply the U.S. government with its smallpox vaccine, along with a new share placement, will provide the company with enough cash to fund operations for the medium term. To win the contract, Acambis had to agree to produce the vaccine in the U.S. Report

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Acambis   Vaccine   contract  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.